Great West Life Assurance CO Arcus Biosciences, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 52,150 shares of RCUS stock, worth $808,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,150
Previous 58,852
11.39%
Holding current value
$808,325
Previous $895,000
10.84%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RCUS
# of Institutions
200Shares Held
51.5MCall Options Held
236KPut Options Held
141K-
Black Rock Inc. New York, NY9.76MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$84.8 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.48MShares$53.9 Million0.48% of portfolio
-
State Street Corp Boston, MA3.01MShares$46.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.44MShares$37.8 Million0.1% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.12B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...